Kraig Labs increases R&D capacity

Kraig Biocraft Laboratories (KBLB) has significantly expanded its research and development capacity to accelerate its Project Atlas initiative. This expansion is driven by breakthroughs in creating new spider silk transgenics, a novel biomaterial with diverse applications. The enhanced R&D capabilities will allow the company to further explore the potential of its advanced materials, aiming to scale production and commercialize its innovative spider silk-based products. This move signals a strong commitment to advancing biotechnology and material science.